EICHORCondition: Myositis · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to evaluate the efficacy and safety of Nipocalimab versus placebo in participants with active idiopathic inflammatory myopathies (IIM).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arizona Arthritis and Rheumatology Research PLLC | Phoenix, Arizona, United States | — |
| HonorHealth Neurology | Scottsdale, Arizona, United States | — |
| Attune Health Autoimmune and Inflamation Care and Research | Beverly Hills, California, United States | — |
| University of California Irvine Medical Center | Orange, California, United States | — |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Torrance, California, United States | — |
| FM Clinical Research, LLC South Florida Neurology Associates, P. A. | Boca Raton, Florida, United States | — |
| Integral Rheumatology And Immunology Specialists | Plantation, Florida, United States | — |
| University of South Florida | Tampa, Florida, United States | — |
| Augusta University | Augusta, Georgia, United States | — |
| University of Kansas Medical Center | Kansas City, Kansas, United States | — |
| Johns Hopkins University | Baltimore, Maryland, United States | — |
| The Brigham and Women's Hospital, Inc. | Boston, Massachusetts, United States | — |
+ 45 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05379634